Imatinib in the first line chronic myeloid leukemia (CML) treatment. Can we compare the real-life data to clinical trial results?

Authors

ŽÁČKOVÁ Daniela KLAMOVÁ H. DUŠEK Ladislav MUŽÍK Jan DOBESOVA B RYŠAVÁ Jaroslava RÁČIL Zdeněk DOUBEK Michael DVOŘÁKOVÁ Dana JURČEK Tomáš RÁZGA Filip MORAVCOVA J POLAKOVA K RULCOVÁ Jarmila CETKOVSKÝ Petr MAYER Jiří

Year of publication 2010
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info